medigraphic.com
ISSN 1405-8871 (Print)

2010, Number 4

<< Back Next >>

Aten Fam 2010; 17 (4)

Pharmacological Approach in the Diabetes Mellitus Type 2 Patient with Emphasis on Timely Insulinization

Abundiz SJ, Guzmán PJE, Gutiérrez JJA, Sandoval MMA, Yáñez OA

Language: Spanish
References: 14
Page: 107-109
116-117
PDF size: 178.11 Kb.


Text Extraction

No abstract


REFERENCES

  1. INNSZ Manual de terapéutica médica. 5ª ed. México: Mcgraw Hill; 2006.

  2. Standards of Medical Care in D, Diabetes Care 2009; 32 (Suppl. 1).

  3. Asian-Pacific Type 2 Diabetes Policy Group, International Diabetes Federation 2005. Type 2 Diabetes Practical Targets and Treatments. 4a ed. Melbourne, Australia.

  4. Bolen S, Wilson L, Vassy J, Feldman L, Yeh J, Marinopoulos S. et al. Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes. Comparative Effectiveness Review No. 8. (Prepared by Johns Hopkins Evidence-based Practice Center) Rockville, MD: Agency for Healthcare Research and Quality, 2007.

  5. Rodbard H, Blonde L, Braithwait S, Brett E, Cobin R, Handelsman Y, et al. Guidelines, Endocr Pract. 2007;13 (Suppl 1): 3-68.

  6. Ariza Andraca R., Álvarez Cisneros T. Prescripción de agentes orales a pacientes con diabetes mellitus tipo 2. Guía de tratamiento Médico. Int Mex 2008;24(1):52-58.

  7. Jeff Unger. Diagnosis and Management of Type 2 Diabetes and Prediabetes Prim Care Clin Office Pract 34,731–759.

  8. Jeff Unger. Current Strategies for Evaluating, Monitoring, and Treating Type 2 Diabetes Mellitus The American Journal of Medicine, 2008; 121 (6A): 20-29.

  9. Ezzo D, Ambizas E. Exenatide Injection (Byetta): Adjunctive Therapy for Glycemic Control Am Aca Fam Phys, 2009; 73(12): 2213-2214.

  10. Tibaldi J. Initiating and Intensifying Insulin Therapy in Type 2 Diabetes Mellitus. The American Journal of Medicine, 2008; 121 (6A): 20-29.

  11. Whitley HP. Sitagliptin (Januvia) for the Treatment of Patients with Type 2 Diabetes Am Fam Phys, 2007; 76(6): 859-860.

  12. Fonseca VA, Kulkarni KD., Review Management of Type 2 Diabetes: Oral Agents, Insulin, and Injectables. Journal of the Am Diet Assoc 2008; 108 (Suppl. 1): 29-33.

  13. Chee W, Egan JM. Incretin-Based Therapies in Type 2 Diabetes Mellitus. J Clin Endocrinol Metab, 2008;93(10):3703–3716

  14. Rosenstein E. Diccionario de Especialidades Farmacéuticas, Insulina Glulisina, [Internet]; [citado 2009 noviembre 21]. Disponible en: www.thompsonplm.com




2020     |     www.medigraphic.com